Movement Alert|SBP GROUP Falls 3.15% in Regular Trading, Innovative Drug Sector Broadly Weak

Market Focus
Yesterday

On October 13, SBP GROUP fell 3.15% in regular trading, trading at HK$5.235/share, with Turnover of HK$48.86 million.

Within the Pharmaceuticals sector where SBP GROUP belongs, sector sentiment was broadly weak. Among individual stocks, CSPC PHARMA fell 2.16%, HENGRUI PHARMA fell 1.65%, HANSOH PHARMA fell 1.33%, HUTCHMED fell 2.53%, and CHINARES PHARMA was flat at 0%.

SBP GROUP is an investment holding company primarily engaged in pharmaceutical operations through three segments: modernized traditional Chinese medicine preparations and western medicines, investment, and others, covering drug R&D, production, and sales.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10